Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Contribution of congenital heart disease to neuropsychiatric outcome in school-age children with 22q11.2 deletion syndrome.
[22q11.2 deletion syndrome]
Children
with
22
q
11
.
2
deletion
syndrome
(
22
q
11
DS
)
present
with
congenital
heart
disease
(
CHD
)
and
high
prevalence
of
psychiatric
disorders
and
neurocognitive
deficits
.
Although
CHD
has
been
implicated
in
neurodevelopment
,
its
role
in
the
neuropsychiatric
outcome
in
22
q
11
DS
is
poorly
understood
.
We
investigated
whether
CHD
contributes
to
the
high
prevalence
of
psychiatric
disorders
and
neurocognitive
impairments
in
22
q
11
DS
.
Fifty
-
four
children
ages
8
-
14
years
with
22
q
11
DS
and
16
age-matched
non-deleted
children
with
CHD
participated
.
They
were
assessed
using
semi-structured
interviews
and
a
Computerized
Neurocognitive
Battery
.
CHD
status
was
assessed
using
available
medical
records
.
Prevalence
of
psychiatric
disorders
and
cognitive
profiles
were
compared
among
the
groups
.
There
were
no
significant
differences
between
the
prevalence
of
psychiatric
disorders
in
the
22
q
11
DS
with
and
without
CHD
.
In
22
q
11
DS
with
CHD
,
the
prevalence
rates
were
41
%
anxiety
disorders
,
37
%
ADHD
and
71
%
psychosis
spectrum
.
In
22
q
11
DS
without
CHD
,
the
rates
were
33
%
anxiety
disorders
,
41
%
ADHD
and
64
%
psychosis
spectrum
.
In
comparison
,
the
non-deleted
CHD
group
had
lower
rates
of
psychopathology
(
25
%
anxiety
disorders
,
6
%
ADHD
,
and
13
%
psychosis
spectrum
)
.
Similarly
,
the
22
q
11
DS
groups
,
regardless
of
CHD
status
,
had
significantly
greater
neurocognitive
deficits
across
multiple
domains
,
compared
to
the
CHD-only
group
.
We
conclude
that
CHD
in
this
sample
of
children
with
22
q
11
.
2
DS
does
not
have
a
major
impact
on
the
prevalence
of
psychiatric
disorders
and
is
not
associated
with
increased
neurocognitive
deficits
.
These
findings
suggest
that
the
22
q
11
.
2
deletion
status
itself
may
confer
significant
neuropsychiatric
vulnerability
in
this
population
.
Diseases
Validation
Diseases presenting
"compared to the chd-only group"
symptom
22q11.2 deletion syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom